|
WHAMM expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.826500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.54810000000084E-05 |
| Normal-vs-Stage2 |
1.506440E-02 |
| Normal-vs-Stage3 |
1.777980E-01 |
| Normal-vs-Stage4 |
7.165800E-02 |
| Stage1-vs-Stage2 |
9.598200E-01 |
| Stage1-vs-Stage3 |
1.246090E-02 |
| Stage1-vs-Stage4 |
1.738220E-01 |
| Stage2-vs-Stage3 |
1.146160E-01 |
| Stage2-vs-Stage4 |
3.843600E-01 |
| Stage3-vs-Stage4 |
5.002800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.736600E-03 |
| Normal-vs-AfricanAmerican |
5.352200E-04 |
| Normal-vs-Asian |
4.42120000054835E-07 |
| Caucasian-vs-AfricanAmerican |
9.945600E-02 |
| Caucasian-vs-Asian |
3.555700E-04 |
| AfricanAmerican-vs-Asian |
4.557300E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.678300E-03 |
| Normal-vs-Female |
1.426020E-04 |
| Male-vs-Female |
8.283700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.062000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.444020E-04 |
| Normal-vs-Age(61-80Yrs) |
9.296400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.592200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.711600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.320800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.384000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.135600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.682800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.864600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.35700000000328E-05 |
| Normal-vs-Grade 2 |
3.977100E-04 |
| Normal-vs-Grade 3 |
5.020500E-03 |
| Normal-vs-Grade 4 |
2.564000E-01 |
| Grade 1-vs-Grade 2 |
4.400300E-02 |
| Grade 1-vs-Grade 3 |
2.484500E-02 |
| Grade 1-vs-Grade 4 |
3.455100E-03 |
| Grade 2-vs-Grade 3 |
4.184000E-01 |
| Grade 2-vs-Grade 4 |
5.732200E-02 |
| Grade 3-vs-Grade 4 |
2.064600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.0857999999977E-05 |
| Normal-vs-ccB subtype |
2.181600E-01 |
| ccA subtype-vs-ccB subtype |
8.561300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.284200E-03 |
| Normal-vs-N1 |
5.645600E-01 |
| N0-vs-N1 |
4.877400E-01 |
|
|
